VMAT2 Inhibitors in the Management of Tardive Dyskinesia: When, How, and in Whom? A Game On! Challenge

0.50 CME
0.50 CNE
$0 FEE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

VMAT2 Inhibitors in the Management of Tardive Dyskinesia: When, How, and in Whom? A Game On! Challenge


Provider Statement

This continuing medical education activity is provided by Vindico Medical Education

Support Statement

This activity is supported by an educational grant from Neurocrine Biosciences, Inc.

There is no non-commercial support for this activity.

Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.

Activity Description

Tardive dyskinesia (TD) is a movement disorder characterized by persistent involuntary movements, most often in the face, that can be debilitating. It is commonly associated with exposure to dopamine receptor antagonists, including both typical and atypical antipsychotics. While symptoms may reverse, in approximately 80% of cases the course of TD is irreversible, yet many patients and providers lack awareness of the causes and symptoms of TD. Despite treatment advances such as VMAT2 inhibitors, providers are unfamiliar with their discrepancies and lack confidence in when, how, and in whom to use these agents. This GameOn activity tests your knowledge of the latest updates in TD diagnosis and treatment.

Target Audience

The intended audience for this activity is psychiatrists, nurses, nurse practitioners, physician assistants and other health care professionals involved in the management of patients with tardive dyskinesia (TD).

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Assess patients at risk for TD for whole body movements, as well as the impact of involuntary movements on quality of life and changes in mental health status, to better identify patients with TD in a timely manner.
  • Apply the latest evidence and guidelines when managing TD in patients being treated with an antipsychotic agent.
  • Optimize VMAT2 treatment selection and timing based on individual patient needs and preferences as well as the latest long-term and real-world evidence.

Actvity Co-Chairs

Leslie Citrome, MD, MPH
Clinical Professor of Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, NY

Joseph P. McEvoy, MD
Professor of Psychiatry and Health Behavior
Medical College of Georgia
Augusta University
Augusta, GA


Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Barbara A. Niedz, PhD, RN, CPHQ


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Vindico Medical Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Vindico Medical Education will provide a maximum of 0.50 contact hours for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME.

American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 0.50 hours credit for completing this program.

This enduring material is approved for 1 year from the date of original release, September 10, 2021, to September 9, 2022.

How to Participate in This Activity and Obtain CE Credit

To participate in this CE activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 66% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate or Contact Hour(s) certificate.


In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. Individuals have a relevant financial relationship if they have a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears below.  

Activity Co-Chairs report the following relationship(s)

Leslie Citrome, MD, MPH
Consultant: Neurocrine, Teva
Speaker Contracted by an Ineligible Company: Neurocrine, Teva

Joseph P. McEvoy, MD
No relevant financial relationships to disclose.

Reviewers report the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Barbara A. Niedz, PhD, RN, CPHQ
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2021 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at cme@vindicoCME.com